Some of Our Customers Share Their Experiences

What Eularis Customers Have to Say

We provide guidance for using advanced AI-powered analytics. Here's what some of our clients have said about working together with us.

team-01.jpg

“I wanted you to know that my VP again mentioned that he was impressed by the marketing mix optimization project and the buzz it has created in the organization!!
So, we should feel very good about how this went! Anyways, thanks for really partnering with me on this.”

Novo Nordisk

Director of Marketing Investments

team-01.jpg
“Eularis is the only Pharmaceutical analytics firm I rate as worth the investment.”                    

Merck

Head of Business Analytics

team-01.jpg

“Your team seem as organized and resourced as one could possibly hope for. You are an indomitable machine. Thanks for all your and your teams efforts.”

 

Shire Pharmaceuticals

Insights Lead

team-01.jpg

“Powerful stuff. In my 20 years of marketing I have never seen such valuable data on my drug brands.”

Pfizer

Specialist Team Lead

team-01.jpg
“Andrée delivers exceptional market research projects with an innovative methodology. The predicted results of market dynamics are remarkably close to reality and implementation of her recommendations has proven to be very successful. I would recommend Andrée’s services to any pharmaceutical company attempting to analyse how to prioritize resources across portfolios.”

Group Product Manager

Boehringer-Ingelheim

team-01.jpg

“Dr. Bates has produced a most valuable resource in the battle to improve patient adherence to medication. Her thorough analysis of the root causes and multi-faceted impact of patient non-adherence are backed up with a strong accessible reference set. Thereis no hiding from the data and Dr. Bates carefully structures a case for fact-based reconsideration of our (the Pharmaceutical Industry’s) abilities to tackle this huge challenge head-on.  At InfoMedics, we find this an invaluable reference guide when engaged in strategic planning work with Pharmaceutical customers. I am of the strong opinion that readers of this report will be significantly wiser after reading it and better armed to design effective and profitable adherence strategies for their companies.”

Infomedics Inc

Michael R. Ball, Ph.D., VP Marketing and Product Management

about-ny-skyline-02-1920x900.jpg
ICON-Results-medal-orange-300x300.png

74%

of launch drugs we have worked on became top brands within 1 year
ICON-Wand-orange-300x300.png

128

Artificial Intelligence powered pharma brand engagements
ICON-DataVis-orange-300x300.png

29-195%

growth achieved by the established brands we have worked on with AI
ICON-Globe-orange-300x300.png

39

Countries that Eularis Analytics have been applied